PHILADELPHIA — A multi-institution group of researchers has found new candidate disease proteins for neurodegenerative disorders. James Shorter, Ph.D., assistant professor of Biochemistry and Biophysics at the Perelman School of Medicine, University of Pennsylvania, Paul Taylor, M.D., PhD, St. Jude Children’s Hospital, and colleagues describe in an advanced online publication of Nature that mutations in prion-like segments of two RNA-binding proteins are associated with a rare inherited degeneration disorder affecting muscle, brain, motor neurons and bone (called multisystem proteinopathy) and one case of the familial form of amyotrophic lateral sclerosis (ALS).
Michael Grandner of the Perelman School of Medicine comments on how exercise can improve sleep quality.
Jonah Berger of the Wharton School is interviewed about his new book, Contagious: Why Things Catch On.
J. Sanford Schwartz and Daniel Rader of the Perelman School of Medicine are quoted about diets.
After seven years of widespread support and alumni participation, the University of Pennsylvania culminated its Making History Campaign, raising $4.3 billion, strengthening Penn’s position among the world’s foremost universities and making major breakthroughs in addressing society’s most complex challenges, Penn President Amy Gutmann announced today.
Dennis Discher of the Perelman School of Medicine discusses the development a protein that could lead to better cancer treatment.
PHILADELPHIA — Lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) are on the rise, according to the American Lung Association and the National Institutes of Health.
These ailments are chronic, affect the small airways of the lung, and are thought to involve an injury-repair cycle that leads to the breakdown of normal airway structure and function. For now, drugs for COPD treat only the symptoms.
Michael Grandner of the Perelman School of Medicine is featured for leading a study on sleep and diet.
Dennis Discher of the School of Engineering and Applied Science is highlighted for leading a research team in developing a way to deliver cancer drugs.
Paul Mitchell’s deep interest in anthropology and in exploring human evolution and variation was sparked by his first course in the fall of 2009 during his freshman year at the University of Pennsylvania.